| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |